ions set forth in the documents relating
to the above financing, risks and uncertainties relating to the development
to completion of the proposed two new and/or expanded hospital facilities
on budget if at all and factors set forth under the heading "Risk Factors"
in our annual report on Form 10-K for the year ended March 31, 2007,
updates and additions to those "Risk Factors" in our interim reports on
Form 10-Q and in other documents filed by us with the Securities and
Exchange Commission from time to time. Forward- looking statements may be
identified by terms such as "may", "will", "should", "could", "expects",
"plans", "intends", "anticipates", "believes", "estimates", "predicts",
"forecasts", "potential", or "continue" or similar terms or the negative of
these terms. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee future
results, levels of activity, performance or achievements. We have no
obligation to update these forward-looking statements.
For more information, please contact:
Judy Zakreski
Lawrence Pemble
Tel: +1-301-215-7777
'/>"/>SOURCE Chindex International, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Neptune Technologies receives GRAS notification in the United States2.
Essilor: New Acquisitions in the United States and Brazil3.
Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States4.
Medical Services Begins Working With United States Companies for Distribution of Its Products5.
United Therapeutics Reports Third Quarter 2007 Financial Results6.
Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States7.
ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office8.
ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India9.
United BioSource Acquires Caro Research, Leader in Simulation Modeling10.
InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom11.
Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States